| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Simian immunodeficiency virus | 182 | 2022 | 846 | 17.330 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 96 | 2022 | 570 | 9.780 |
Why?
|
| Macaca mulatta | 170 | 2022 | 2375 | 5.790 |
Why?
|
| SAIDS Vaccines | 29 | 2021 | 166 | 5.200 |
Why?
|
| Rhadinovirus | 20 | 2021 | 37 | 5.150 |
Why?
|
| Viral Envelope Proteins | 32 | 2021 | 635 | 3.520 |
Why?
|
| Gene Products, env | 27 | 2018 | 263 | 3.400 |
Why?
|
| AIDS Vaccines | 31 | 2023 | 938 | 3.310 |
Why?
|
| Virus Replication | 77 | 2019 | 2535 | 3.100 |
Why?
|
| Antibodies, Viral | 69 | 2022 | 3175 | 2.860 |
Why?
|
| HIV Envelope Protein gp120 | 27 | 2019 | 952 | 2.800 |
Why?
|
| Herpesviridae Infections | 17 | 2020 | 277 | 2.740 |
Why?
|
| HIV-1 | 60 | 2021 | 6939 | 2.720 |
Why?
|
| Herpesvirus 2, Saimiriine | 42 | 2005 | 61 | 2.380 |
Why?
|
| Dependovirus | 10 | 2020 | 705 | 2.240 |
Why?
|
| Genetic Vectors | 20 | 2021 | 3421 | 2.170 |
Why?
|
| Viral Regulatory and Accessory Proteins | 9 | 2020 | 159 | 1.890 |
Why?
|
| Genes, nef | 26 | 2005 | 55 | 1.770 |
Why?
|
| Herpesvirus 8, Human | 13 | 2021 | 258 | 1.610 |
Why?
|
| Genes, Viral | 34 | 2005 | 718 | 1.610 |
Why?
|
| Viral Proteins | 22 | 2021 | 1899 | 1.590 |
Why?
|
| Neutralization Tests | 40 | 2019 | 757 | 1.530 |
Why?
|
| Retroviridae Proteins | 12 | 2014 | 98 | 1.500 |
Why?
|
| Receptor, EphA2 | 3 | 2014 | 42 | 1.440 |
Why?
|
| Antibodies, Monoclonal | 26 | 2021 | 9272 | 1.370 |
Why?
|
| HIV Antibodies | 16 | 2021 | 1322 | 1.350 |
Why?
|
| Viral Fusion Proteins | 11 | 2011 | 96 | 1.320 |
Why?
|
| Gene Products, gag | 9 | 2020 | 337 | 1.320 |
Why?
|
| Tumor Virus Infections | 16 | 2010 | 454 | 1.310 |
Why?
|
| Cell Line | 91 | 2020 | 15993 | 1.310 |
Why?
|
| Molecular Sequence Data | 94 | 2015 | 18107 | 1.300 |
Why?
|
| Gene Products, nef | 13 | 2019 | 110 | 1.290 |
Why?
|
| HIV Envelope Protein gp41 | 7 | 2021 | 314 | 1.230 |
Why?
|
| DNA, Viral | 61 | 2017 | 2226 | 1.220 |
Why?
|
| Virion | 14 | 2019 | 433 | 1.220 |
Why?
|
| Amino Acid Sequence | 76 | 2019 | 13809 | 1.200 |
Why?
|
| Retroviridae Proteins, Oncogenic | 11 | 2011 | 76 | 1.190 |
Why?
|
| Membrane Glycoproteins | 19 | 2015 | 3769 | 1.190 |
Why?
|
| Antibodies, Neutralizing | 18 | 2022 | 1978 | 1.170 |
Why?
|
| Genome, Viral | 12 | 2018 | 665 | 1.120 |
Why?
|
| Viral Vaccines | 18 | 2019 | 636 | 1.070 |
Why?
|
| Vaccines, Attenuated | 25 | 2012 | 342 | 1.060 |
Why?
|
| Gammaherpesvirinae | 2 | 2018 | 27 | 1.060 |
Why?
|
| Animals | 288 | 2022 | 168660 | 1.050 |
Why?
|
| HIV Infections | 34 | 2023 | 16715 | 1.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 29 | 2023 | 2232 | 1.030 |
Why?
|
| Gene Deletion | 14 | 2020 | 2749 | 1.030 |
Why?
|
| Virus Internalization | 6 | 2021 | 501 | 1.010 |
Why?
|
| Codon | 8 | 2015 | 611 | 1.010 |
Why?
|
| Ephrins | 2 | 2014 | 27 | 0.990 |
Why?
|
| Herpesviridae | 7 | 2019 | 109 | 0.970 |
Why?
|
| Viral Load | 27 | 2020 | 3300 | 0.920 |
Why?
|
| Base Sequence | 74 | 2018 | 12798 | 0.900 |
Why?
|
| Gene Expression Regulation, Viral | 7 | 2015 | 442 | 0.850 |
Why?
|
| Glycoproteins | 11 | 2018 | 2266 | 0.850 |
Why?
|
| Oncogene Proteins, Viral | 14 | 2005 | 362 | 0.820 |
Why?
|
| Retroviridae Infections | 21 | 1997 | 151 | 0.820 |
Why?
|
| Simian T-lymphotropic virus 1 | 3 | 2017 | 6 | 0.810 |
Why?
|
| Monkey Diseases | 13 | 2010 | 77 | 0.800 |
Why?
|
| Gene Products, tax | 3 | 2017 | 51 | 0.800 |
Why?
|
| Dengue Virus | 3 | 2017 | 204 | 0.780 |
Why?
|
| Galactokinase | 2 | 2017 | 16 | 0.770 |
Why?
|
| Dengue Vaccines | 2 | 2017 | 14 | 0.770 |
Why?
|
| Glycosylation | 13 | 2019 | 1129 | 0.760 |
Why?
|
| DNA, Recombinant | 5 | 2016 | 476 | 0.760 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 4 | 2021 | 371 | 0.750 |
Why?
|
| Sequence Deletion | 11 | 2008 | 1524 | 0.730 |
Why?
|
| Lymphocyte Activation | 23 | 2019 | 5524 | 0.730 |
Why?
|
| Epitopes | 13 | 2019 | 2570 | 0.690 |
Why?
|
| HIV | 12 | 2017 | 1604 | 0.690 |
Why?
|
| HEK293 Cells | 14 | 2019 | 4204 | 0.680 |
Why?
|
| Retroviridae | 18 | 2001 | 913 | 0.670 |
Why?
|
| Small Molecule Libraries | 2 | 2014 | 718 | 0.650 |
Why?
|
| Immunity, Cellular | 10 | 2019 | 1608 | 0.650 |
Why?
|
| Macaca | 25 | 2017 | 439 | 0.640 |
Why?
|
| Genes, env | 9 | 1995 | 95 | 0.630 |
Why?
|
| Viremia | 10 | 2020 | 736 | 0.630 |
Why?
|
| B-Lymphocytes | 9 | 2020 | 4665 | 0.620 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2017 | 16 | 0.610 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2017 | 65 | 0.600 |
Why?
|
| T-Lymphocytes | 29 | 2021 | 10179 | 0.600 |
Why?
|
| HTLV-I Infections | 1 | 2017 | 101 | 0.600 |
Why?
|
| Mutagenesis, Site-Directed | 18 | 2014 | 1723 | 0.590 |
Why?
|
| HIV-2 | 7 | 2015 | 167 | 0.590 |
Why?
|
| Protein Binding | 10 | 2018 | 9377 | 0.590 |
Why?
|
| Polymerase Chain Reaction | 24 | 2017 | 6170 | 0.580 |
Why?
|
| Oncogenes | 11 | 1999 | 1265 | 0.570 |
Why?
|
| Immunoglobulin G | 6 | 2019 | 4561 | 0.570 |
Why?
|
| Carbohydrates | 3 | 2015 | 394 | 0.570 |
Why?
|
| Transfection | 24 | 2015 | 5892 | 0.560 |
Why?
|
| Cell Transformation, Viral | 14 | 2006 | 566 | 0.560 |
Why?
|
| DNA Primers | 21 | 2015 | 2891 | 0.560 |
Why?
|
| CD8-Positive T-Lymphocytes | 19 | 2020 | 4477 | 0.550 |
Why?
|
| Macrophages | 22 | 2020 | 5651 | 0.540 |
Why?
|
| Recombination, Genetic | 12 | 2011 | 1586 | 0.530 |
Why?
|
| RNA, Viral | 24 | 2017 | 2901 | 0.530 |
Why?
|
| Virus Assembly | 3 | 2012 | 144 | 0.520 |
Why?
|
| Cercocebus atys | 3 | 2010 | 12 | 0.500 |
Why?
|
| Dengue | 1 | 2017 | 256 | 0.480 |
Why?
|
| Virology | 2 | 2021 | 76 | 0.470 |
Why?
|
| Encephalitis, Viral | 1 | 2014 | 55 | 0.460 |
Why?
|
| Lentivirus | 5 | 2005 | 503 | 0.460 |
Why?
|
| Genes, vpr | 7 | 1999 | 21 | 0.460 |
Why?
|
| RNA-Directed DNA Polymerase | 4 | 2020 | 248 | 0.460 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 13 | 2020 | 3874 | 0.450 |
Why?
|
| Sequence Alignment | 11 | 2015 | 2256 | 0.430 |
Why?
|
| Viral Tropism | 1 | 2013 | 101 | 0.430 |
Why?
|
| Drug Carriers | 1 | 2017 | 690 | 0.430 |
Why?
|
| Peptide Fragments | 9 | 2019 | 5096 | 0.410 |
Why?
|
| Cloning, Molecular | 24 | 2007 | 4320 | 0.410 |
Why?
|
| NF-kappa B | 5 | 2012 | 2500 | 0.400 |
Why?
|
| Simplexvirus | 3 | 2006 | 803 | 0.400 |
Why?
|
| Vaccines, Synthetic | 6 | 2019 | 634 | 0.370 |
Why?
|
| Plant Lectins | 1 | 2010 | 104 | 0.370 |
Why?
|
| Mannose | 1 | 2010 | 124 | 0.360 |
Why?
|
| Humans | 167 | 2023 | 743811 | 0.360 |
Why?
|
| Plasmids | 10 | 2015 | 2308 | 0.350 |
Why?
|
| T-Lymphocytes, Cytotoxic | 13 | 2019 | 1821 | 0.350 |
Why?
|
| Cells, Cultured | 29 | 2019 | 19232 | 0.340 |
Why?
|
| Histocompatibility Antigens Class I | 6 | 2019 | 1366 | 0.340 |
Why?
|
| Gene Products, vif | 2 | 2019 | 33 | 0.340 |
Why?
|
| HIV Long Terminal Repeat | 3 | 1997 | 88 | 0.330 |
Why?
|
| Primates | 7 | 2016 | 545 | 0.330 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 8 | 1997 | 798 | 0.330 |
Why?
|
| Vaccines, DNA | 4 | 2006 | 305 | 0.320 |
Why?
|
| Mutation | 29 | 2020 | 29777 | 0.320 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 436 | 0.310 |
Why?
|
| Genes, tat | 2 | 1997 | 15 | 0.310 |
Why?
|
| Amino Acid Substitution | 6 | 2017 | 1793 | 0.310 |
Why?
|
| Haplorhini | 7 | 2009 | 548 | 0.300 |
Why?
|
| Antibody Specificity | 8 | 2021 | 1095 | 0.300 |
Why?
|
| Mutagenesis | 9 | 2005 | 1263 | 0.300 |
Why?
|
| Disease Models, Animal | 24 | 2017 | 18027 | 0.290 |
Why?
|
| Antigens, Viral | 12 | 2020 | 1035 | 0.290 |
Why?
|
| Receptors, Virus | 3 | 2019 | 649 | 0.280 |
Why?
|
| Antibody Formation | 10 | 2019 | 1402 | 0.270 |
Why?
|
| Polymorphism, Genetic | 4 | 2010 | 4326 | 0.270 |
Why?
|
| Gene Knockout Techniques | 3 | 2017 | 807 | 0.270 |
Why?
|
| Antigenic Variation | 5 | 2002 | 125 | 0.270 |
Why?
|
| Vaccination | 14 | 2020 | 3275 | 0.260 |
Why?
|
| Interferon-gamma | 9 | 2017 | 3205 | 0.260 |
Why?
|
| Sequence Homology, Amino Acid | 14 | 2001 | 2839 | 0.260 |
Why?
|
| Immunity, Humoral | 4 | 2019 | 598 | 0.260 |
Why?
|
| RNA, Messenger | 12 | 2011 | 13028 | 0.250 |
Why?
|
| Blotting, Western | 8 | 2012 | 5179 | 0.250 |
Why?
|
| Immunity | 2 | 2020 | 1013 | 0.250 |
Why?
|
| Fibroblasts | 2 | 2013 | 4162 | 0.250 |
Why?
|
| Pan troglodytes | 5 | 2010 | 229 | 0.240 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 3 | 2017 | 222 | 0.240 |
Why?
|
| Peptides | 6 | 2012 | 4406 | 0.240 |
Why?
|
| Open Reading Frames | 9 | 2011 | 811 | 0.240 |
Why?
|
| Immunodominant Epitopes | 3 | 2017 | 267 | 0.240 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 6 | 2002 | 153 | 0.240 |
Why?
|
| Endothelial Cells | 2 | 2014 | 3482 | 0.230 |
Why?
|
| Species Specificity | 8 | 2015 | 2480 | 0.230 |
Why?
|
| Cell Membrane | 4 | 2011 | 3749 | 0.230 |
Why?
|
| Conserved Sequence | 6 | 2018 | 1202 | 0.230 |
Why?
|
| Phylogeny | 8 | 2017 | 2796 | 0.220 |
Why?
|
| Evolution, Molecular | 5 | 2008 | 1940 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2012 | 2914 | 0.220 |
Why?
|
| Recombinant Proteins | 12 | 2021 | 6620 | 0.220 |
Why?
|
| Chromosome Deletion | 7 | 1992 | 1396 | 0.210 |
Why?
|
| COS Cells | 9 | 2000 | 1161 | 0.210 |
Why?
|
| Macrophages, Alveolar | 3 | 2000 | 407 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 8 | 1999 | 2942 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 8 | 2017 | 4803 | 0.200 |
Why?
|
| Papio | 4 | 2016 | 656 | 0.200 |
Why?
|
| Cell Line, Transformed | 7 | 2006 | 897 | 0.200 |
Why?
|
| Phosphoproteins | 6 | 1998 | 2440 | 0.190 |
Why?
|
| Kinetics | 9 | 2020 | 6476 | 0.190 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 2123 | 0.190 |
Why?
|
| Immunization | 4 | 2005 | 1255 | 0.190 |
Why?
|
| Sarcoma, Kaposi | 3 | 1999 | 370 | 0.190 |
Why?
|
| Genetic Variation | 12 | 2014 | 6535 | 0.190 |
Why?
|
| Virulence | 8 | 2005 | 1328 | 0.190 |
Why?
|
| Spleen | 6 | 2014 | 2359 | 0.190 |
Why?
|
| Lymphoid Tissue | 6 | 2008 | 454 | 0.190 |
Why?
|
| Glycoside Hydrolases | 1 | 2000 | 133 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 5 | 2014 | 2086 | 0.190 |
Why?
|
| RNA, Small Nuclear | 4 | 2005 | 64 | 0.180 |
Why?
|
| Nucleotides | 3 | 2020 | 463 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2005 | 5021 | 0.180 |
Why?
|
| Deltaretrovirus | 7 | 1994 | 170 | 0.180 |
Why?
|
| Receptor, EphA7 | 1 | 2019 | 6 | 0.180 |
Why?
|
| Immunization, Secondary | 8 | 2020 | 340 | 0.180 |
Why?
|
| Molecular Weight | 10 | 1995 | 2253 | 0.170 |
Why?
|
| Herpesvirus 4, Human | 5 | 2021 | 1041 | 0.170 |
Why?
|
| Gene Expression | 6 | 2014 | 7793 | 0.170 |
Why?
|
| Polysaccharides | 4 | 2022 | 1058 | 0.170 |
Why?
|
| Antigens, CD | 4 | 2020 | 4026 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 12 | 2016 | 4386 | 0.170 |
Why?
|
| Lentivirus Infections | 2 | 1997 | 12 | 0.170 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 1988 | 547 | 0.160 |
Why?
|
| DNA Restriction Enzymes | 12 | 1995 | 570 | 0.160 |
Why?
|
| Immune Evasion | 2 | 2019 | 360 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 1997 | 1085 | 0.160 |
Why?
|
| Receptors, Chemokine | 3 | 2000 | 670 | 0.160 |
Why?
|
| Genes, Reporter | 5 | 2014 | 1545 | 0.160 |
Why?
|
| Receptors, Eph Family | 1 | 2018 | 44 | 0.160 |
Why?
|
| Genes, vif | 4 | 2004 | 17 | 0.160 |
Why?
|
| Papio anubis | 1 | 2017 | 25 | 0.160 |
Why?
|
| Lymphocytes | 13 | 2005 | 2615 | 0.160 |
Why?
|
| Time Factors | 14 | 2021 | 40038 | 0.150 |
Why?
|
| Vagina | 3 | 2016 | 825 | 0.150 |
Why?
|
| Alleles | 6 | 2018 | 6934 | 0.150 |
Why?
|
| Primate Diseases | 2 | 2013 | 15 | 0.150 |
Why?
|
| Point Mutation | 5 | 1998 | 1623 | 0.150 |
Why?
|
| Glucans | 1 | 2017 | 71 | 0.150 |
Why?
|
| Laboratory Animal Science | 1 | 1997 | 9 | 0.150 |
Why?
|
| Ovalbumin | 1 | 2019 | 719 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 9 | 2016 | 1836 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 4 | 2020 | 3847 | 0.150 |
Why?
|
| Macaca fascicularis | 3 | 2010 | 915 | 0.150 |
Why?
|
| Cercopithecidae | 4 | 1991 | 22 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2004 | 3772 | 0.140 |
Why?
|
| Podophyllin | 1 | 1996 | 2 | 0.140 |
Why?
|
| Deltaretrovirus Infections | 1 | 2016 | 26 | 0.140 |
Why?
|
| Binding Sites | 9 | 2016 | 6111 | 0.140 |
Why?
|
| Sp1 Transcription Factor | 1 | 1997 | 144 | 0.140 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 1997 | 1369 | 0.140 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1997 | 118 | 0.140 |
Why?
|
| Simian virus 40 | 2 | 1996 | 297 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 3 | 1998 | 5867 | 0.140 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 2865 | 0.140 |
Why?
|
| Rectum | 2 | 2019 | 904 | 0.140 |
Why?
|
| Lymph Nodes | 13 | 2014 | 3476 | 0.130 |
Why?
|
| Viral Structural Proteins | 3 | 1992 | 103 | 0.130 |
Why?
|
| Rabbits | 7 | 2011 | 4894 | 0.130 |
Why?
|
| Drug Resistance, Viral | 2 | 2010 | 820 | 0.130 |
Why?
|
| Proteome | 3 | 2020 | 1794 | 0.130 |
Why?
|
| Methylation | 12 | 1994 | 1104 | 0.130 |
Why?
|
| Cytoplasm | 3 | 2014 | 1536 | 0.130 |
Why?
|
| Receptors, CCR5 | 5 | 2015 | 498 | 0.130 |
Why?
|
| Purines | 1 | 1998 | 590 | 0.130 |
Why?
|
| B-Lymphocyte Subsets | 1 | 1996 | 246 | 0.130 |
Why?
|
| Restriction Mapping | 6 | 1996 | 878 | 0.120 |
Why?
|
| Transduction, Genetic | 2 | 2016 | 913 | 0.120 |
Why?
|
| Academies and Institutes | 1 | 1997 | 317 | 0.120 |
Why?
|
| Threonine | 1 | 2015 | 279 | 0.120 |
Why?
|
| Blotting, Northern | 3 | 2011 | 1581 | 0.120 |
Why?
|
| Flow Cytometry | 9 | 2017 | 5973 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2005 | 7880 | 0.120 |
Why?
|
| Peyer's Patches | 1 | 2014 | 121 | 0.120 |
Why?
|
| Mucins | 1 | 2017 | 564 | 0.120 |
Why?
|
| Transcription, Genetic | 8 | 2006 | 7719 | 0.120 |
Why?
|
| Plasma Cells | 1 | 2017 | 593 | 0.120 |
Why?
|
| Clinical Trials as Topic | 4 | 2023 | 7908 | 0.120 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 553 | 0.120 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 349 | 0.120 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 1994 | 40 | 0.120 |
Why?
|
| src-Family Kinases | 2 | 1998 | 551 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2000 | 1311 | 0.120 |
Why?
|
| Luciferases | 1 | 2015 | 733 | 0.110 |
Why?
|
| Hot Temperature | 3 | 1989 | 1351 | 0.110 |
Why?
|
| Gene Products, vpr | 2 | 2005 | 36 | 0.110 |
Why?
|
| Chemokines | 2 | 2016 | 968 | 0.110 |
Why?
|
| Histones | 3 | 1989 | 2598 | 0.110 |
Why?
|
| MicroRNAs | 4 | 2019 | 3750 | 0.110 |
Why?
|
| Selection, Genetic | 2 | 2017 | 914 | 0.110 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2013 | 130 | 0.110 |
Why?
|
| Proviruses | 4 | 1997 | 318 | 0.110 |
Why?
|
| Transgenes | 1 | 2016 | 1008 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 10 | 1989 | 1374 | 0.110 |
Why?
|
| Major Histocompatibility Complex | 2 | 2010 | 936 | 0.110 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1992 | 156 | 0.110 |
Why?
|
| RNA, Transfer, Lys | 2 | 2002 | 9 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2017 | 4422 | 0.100 |
Why?
|
| Cyclins | 1 | 1994 | 603 | 0.100 |
Why?
|
| DNA, Complementary | 1 | 2015 | 2050 | 0.100 |
Why?
|
| Immunologic Memory | 4 | 2021 | 1347 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2016 | 1098 | 0.100 |
Why?
|
| Lymphoma | 7 | 1998 | 1875 | 0.100 |
Why?
|
| Cytokines | 5 | 2019 | 7324 | 0.100 |
Why?
|
| Retroviruses, Simian | 1 | 1991 | 12 | 0.100 |
Why?
|
| Immunoglobulins | 1 | 2015 | 881 | 0.100 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2012 | 307 | 0.100 |
Why?
|
| Artocarpus | 1 | 2010 | 2 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2005 | 2540 | 0.100 |
Why?
|
| Immune Sera | 2 | 2002 | 641 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 1997 | 2725 | 0.100 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1994 | 671 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 4 | 2011 | 1799 | 0.090 |
Why?
|
| Protein Precursors | 2 | 1995 | 1154 | 0.090 |
Why?
|
| Structure-Activity Relationship | 6 | 1997 | 3128 | 0.090 |
Why?
|
| Vesicular Transport Proteins | 2 | 2005 | 377 | 0.090 |
Why?
|
| Gene Products, tat | 2 | 2001 | 120 | 0.090 |
Why?
|
| Vaccinia virus | 4 | 2003 | 349 | 0.090 |
Why?
|
| Thymine Nucleotides | 2 | 1989 | 63 | 0.090 |
Why?
|
| HeLa Cells | 2 | 2015 | 3130 | 0.090 |
Why?
|
| ras Proteins | 1 | 1995 | 1059 | 0.090 |
Why?
|
| Alkaline Phosphatase | 3 | 2006 | 866 | 0.090 |
Why?
|
| Epitopes, T-Lymphocyte | 4 | 2019 | 880 | 0.090 |
Why?
|
| HIV Reverse Transcriptase | 2 | 2002 | 213 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2203 | 0.090 |
Why?
|
| Sequence Homology | 1 | 2010 | 203 | 0.090 |
Why?
|
| Cercopithecus | 1 | 1989 | 7 | 0.090 |
Why?
|
| Reoviridae | 4 | 1979 | 161 | 0.090 |
Why?
|
| Thymidine Monophosphate | 1 | 1989 | 2 | 0.090 |
Why?
|
| Blood Vessels | 2 | 2014 | 1124 | 0.090 |
Why?
|
| Aotus trivirgatus | 7 | 1986 | 37 | 0.090 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 1989 | 87 | 0.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2004 | 985 | 0.090 |
Why?
|
| Signal Transduction | 6 | 2000 | 23398 | 0.090 |
Why?
|
| Sequence Analysis | 2 | 2001 | 256 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1787 | 0.080 |
Why?
|
| Research | 2 | 2000 | 1999 | 0.080 |
Why?
|
| GTP-Binding Proteins | 2 | 2005 | 969 | 0.080 |
Why?
|
| Protein Conformation | 5 | 2014 | 4009 | 0.080 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 3706 | 0.080 |
Why?
|
| Killer Cells, Natural | 4 | 1996 | 2131 | 0.080 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1998 | 91 | 0.080 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 1990 | 142 | 0.080 |
Why?
|
| Disease Transmission, Infectious | 1 | 1994 | 546 | 0.080 |
Why?
|
| Models, Molecular | 4 | 2014 | 5445 | 0.080 |
Why?
|
| Gene Library | 2 | 2006 | 1074 | 0.080 |
Why?
|
| Jurkat Cells | 3 | 2017 | 743 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 626 | 0.080 |
Why?
|
| Endocytosis | 1 | 2012 | 985 | 0.080 |
Why?
|
| History, 21st Century | 2 | 2021 | 1532 | 0.080 |
Why?
|
| Lectins | 1 | 2010 | 513 | 0.080 |
Why?
|
| Saimiri | 3 | 1998 | 330 | 0.080 |
Why?
|
| Cytopathogenic Effect, Viral | 3 | 2002 | 156 | 0.070 |
Why?
|
| Ligands | 1 | 2014 | 3281 | 0.070 |
Why?
|
| Kidney | 7 | 2011 | 7185 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2015 | 1986 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2014 | 1358 | 0.070 |
Why?
|
| Virus Integration | 2 | 1999 | 299 | 0.070 |
Why?
|
| Cosmids | 1 | 2006 | 107 | 0.070 |
Why?
|
| Leukemia, Experimental | 2 | 1987 | 246 | 0.070 |
Why?
|
| Mannose-Binding Lectin | 1 | 2007 | 150 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2021 | 421 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2021 | 2736 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 4 | 1999 | 2560 | 0.070 |
Why?
|
| Cebidae | 2 | 1982 | 21 | 0.070 |
Why?
|
| HIV Core Protein p24 | 1 | 2005 | 256 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2000 | 5854 | 0.070 |
Why?
|
| Callithrix | 4 | 2014 | 93 | 0.070 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 2004 | 8 | 0.060 |
Why?
|
| Genes, pol | 1 | 2004 | 51 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3591 | 0.060 |
Why?
|
| Monocytes | 2 | 2014 | 2593 | 0.060 |
Why?
|
| Genes, vpu | 2 | 1994 | 6 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2000 | 2453 | 0.060 |
Why?
|
| Ethiopia | 3 | 1994 | 495 | 0.060 |
Why?
|
| Macaca nemestrina | 3 | 1999 | 23 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2017 | 2969 | 0.060 |
Why?
|
| Codon, Nonsense | 1 | 2005 | 281 | 0.060 |
Why?
|
| Disease Progression | 5 | 2000 | 13273 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2007 | 589 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 2861 | 0.060 |
Why?
|
| Rats | 8 | 1999 | 24250 | 0.060 |
Why?
|
| Serial Passage | 1 | 2003 | 23 | 0.060 |
Why?
|
| Interleukin-2 | 5 | 1999 | 1904 | 0.060 |
Why?
|
| DNA Replication | 3 | 1987 | 1399 | 0.060 |
Why?
|
| Science | 1 | 2006 | 239 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 2005 | 906 | 0.060 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 1988 | 671 | 0.060 |
Why?
|
| Immunophenotyping | 4 | 2006 | 1880 | 0.060 |
Why?
|
| Prisoners | 1 | 2006 | 297 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2017 | 63042 | 0.060 |
Why?
|
| Lymphocyte Depletion | 1 | 2005 | 608 | 0.060 |
Why?
|
| Heterozygote | 1 | 2010 | 2803 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 2 | 1997 | 486 | 0.060 |
Why?
|
| Cytomegalovirus | 2 | 2003 | 733 | 0.050 |
Why?
|
| Growth Hormone | 1 | 1985 | 705 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 1991 | 1466 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2712 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 399 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2000 | 8436 | 0.050 |
Why?
|
| Immunization Schedule | 2 | 2019 | 221 | 0.050 |
Why?
|
| Salmonella | 1 | 2003 | 129 | 0.050 |
Why?
|
| Protein Denaturation | 2 | 2000 | 237 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 9648 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2001 | 1157 | 0.050 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2001 | 19 | 0.050 |
Why?
|
| RNA, Neoplasm | 2 | 1975 | 769 | 0.050 |
Why?
|
| Drosophila melanogaster | 2 | 1989 | 1712 | 0.050 |
Why?
|
| Social Justice | 1 | 2006 | 457 | 0.050 |
Why?
|
| Antigens, CD20 | 1 | 2003 | 199 | 0.050 |
Why?
|
| Immunity, Mucosal | 2 | 2003 | 490 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2007 | 1188 | 0.050 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 28 | 0.050 |
Why?
|
| Gene Products, rev | 1 | 2001 | 31 | 0.050 |
Why?
|
| Gene Products, pol | 1 | 2001 | 47 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2003 | 482 | 0.050 |
Why?
|
| RNA | 4 | 2002 | 2748 | 0.050 |
Why?
|
| Clonal Anergy | 1 | 2002 | 169 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 2916 | 0.050 |
Why?
|
| Terminal Repeat Sequences | 1 | 2001 | 72 | 0.050 |
Why?
|
| Cytosine | 1 | 1982 | 216 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1602 | 0.050 |
Why?
|
| Female | 20 | 2021 | 380020 | 0.050 |
Why?
|
| Virus Cultivation | 2 | 2013 | 92 | 0.050 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 127 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2010 | 2566 | 0.050 |
Why?
|
| Phenotype | 8 | 2007 | 16361 | 0.050 |
Why?
|
| Virus Latency | 2 | 2006 | 358 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 464 | 0.050 |
Why?
|
| Mice | 13 | 2019 | 81154 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2014 | 10251 | 0.050 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 39 | 0.050 |
Why?
|
| Organophosphorus Compounds | 1 | 2001 | 213 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2001 | 378 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 4 | 2007 | 914 | 0.050 |
Why?
|
| Interferons | 3 | 1979 | 706 | 0.050 |
Why?
|
| Genetic Engineering | 3 | 2000 | 950 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2000 | 210 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2002 | 276 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 1988 | 12066 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2000 | 12209 | 0.040 |
Why?
|
| Interleukin-6 | 3 | 2000 | 3208 | 0.040 |
Why?
|
| Enzyme Precursors | 1 | 2000 | 176 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2009 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2004 | 841 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2002 | 467 | 0.040 |
Why?
|
| Mammalian orthoreovirus 3 | 1 | 1979 | 44 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2649 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2019 | 1224 | 0.040 |
Why?
|
| Lymphoma, Primary Effusion | 1 | 2019 | 17 | 0.040 |
Why?
|
| Immunocompetence | 1 | 1999 | 136 | 0.040 |
Why?
|
| Haplotypes | 2 | 2010 | 2779 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2000 | 262 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2000 | 212 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2021 | 570 | 0.040 |
Why?
|
| HIV Long-Term Survivors | 1 | 1999 | 126 | 0.040 |
Why?
|
| Mice, Nude | 2 | 1999 | 3680 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 1976 | 2217 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 5 | 1998 | 2503 | 0.040 |
Why?
|
| Viral Interference | 1 | 1998 | 12 | 0.040 |
Why?
|
| Pulmonary Alveoli | 3 | 1991 | 674 | 0.040 |
Why?
|
| Exanthema | 2 | 1998 | 501 | 0.040 |
Why?
|
| DNA | 1 | 1993 | 7295 | 0.040 |
Why?
|
| Luminescent Proteins | 2 | 1999 | 853 | 0.040 |
Why?
|
| HLA Antigens | 2 | 2004 | 1382 | 0.040 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 3038 | 0.040 |
Why?
|
| Protein Kinases | 3 | 1995 | 1640 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 2000 | 422 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 1677 | 0.040 |
Why?
|
| Immune System | 1 | 2004 | 807 | 0.040 |
Why?
|
| Safety | 2 | 1994 | 1184 | 0.040 |
Why?
|
| Male | 21 | 2021 | 349776 | 0.040 |
Why?
|
| Attachment Sites, Microbiological | 1 | 1997 | 26 | 0.040 |
Why?
|
| Drosophila | 1 | 1985 | 1494 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2000 | 1422 | 0.040 |
Why?
|
| Reassortant Viruses | 1 | 1997 | 37 | 0.040 |
Why?
|
| Models, Biological | 3 | 2009 | 9582 | 0.040 |
Why?
|
| Thymus Gland | 2 | 1998 | 1266 | 0.040 |
Why?
|
| Lymphatic Diseases | 1 | 1999 | 323 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2000 | 381 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2000 | 465 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2010 | 2984 | 0.040 |
Why?
|
| Human T-lymphotropic virus 2 | 1 | 1997 | 10 | 0.040 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1997 | 170 | 0.040 |
Why?
|
| Sterilization | 1 | 1998 | 133 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1989 | 1596 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1989 | 769 | 0.040 |
Why?
|
| 3T3 Cells | 2 | 1997 | 1102 | 0.040 |
Why?
|
| Animals, Wild | 2 | 1994 | 88 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2017 | 781 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2005 | 4221 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2004 | 3000 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2006 | 1771 | 0.040 |
Why?
|
| Mesocestoides | 1 | 1996 | 2 | 0.040 |
Why?
|
| Cestode Infections | 1 | 1996 | 6 | 0.040 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1997 | 146 | 0.040 |
Why?
|
| Lung Diseases, Parasitic | 1 | 1996 | 14 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 6311 | 0.040 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 1996 | 38 | 0.040 |
Why?
|
| Podophyllotoxin | 1 | 1996 | 21 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1997 | 226 | 0.040 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1997 | 140 | 0.040 |
Why?
|
| Foundations | 1 | 1997 | 94 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 1 | 2003 | 820 | 0.040 |
Why?
|
| Callitrichinae | 3 | 1986 | 23 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2016 | 363 | 0.030 |
Why?
|
| Hemophilia A | 1 | 1999 | 351 | 0.030 |
Why?
|
| Adenine | 1 | 2001 | 935 | 0.030 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1996 | 68 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 2016 | 414 | 0.030 |
Why?
|
| Fetal Death | 1 | 2018 | 448 | 0.030 |
Why?
|
| Cell Division | 6 | 2002 | 4568 | 0.030 |
Why?
|
| Guanosine Diphosphate | 1 | 1995 | 85 | 0.030 |
Why?
|
| HIV Seropositivity | 2 | 1995 | 971 | 0.030 |
Why?
|
| Adenine Nucleotides | 1 | 1976 | 121 | 0.030 |
Why?
|
| Leukocyte Count | 3 | 1998 | 1588 | 0.030 |
Why?
|
| Phosphoserine | 2 | 1995 | 206 | 0.030 |
Why?
|
| Methyltransferases | 4 | 1988 | 367 | 0.030 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1996 | 318 | 0.030 |
Why?
|
| HIV Antigens | 2 | 1997 | 347 | 0.030 |
Why?
|
| Viral Core Proteins | 2 | 2002 | 162 | 0.030 |
Why?
|
| PC12 Cells | 1 | 1995 | 331 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 972 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 474 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1995 | 441 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 192 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1995 | 211 | 0.030 |
Why?
|
| Integrases | 1 | 1997 | 533 | 0.030 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1995 | 111 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1995 | 321 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1995 | 211 | 0.030 |
Why?
|
| Moths | 1 | 1994 | 85 | 0.030 |
Why?
|
| Radioimmunoprecipitation Assay | 1 | 1994 | 16 | 0.030 |
Why?
|
| Genotype | 3 | 2005 | 12944 | 0.030 |
Why?
|
| Antigens | 2 | 2008 | 1466 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 1996 | 645 | 0.030 |
Why?
|
| Oligosaccharides | 1 | 2016 | 415 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1995 | 494 | 0.030 |
Why?
|
| New York | 1 | 1997 | 885 | 0.030 |
Why?
|
| Amino Acids | 2 | 1993 | 1733 | 0.030 |
Why?
|
| Tyrosine | 2 | 1995 | 1462 | 0.030 |
Why?
|
| Muscles | 1 | 2019 | 1613 | 0.030 |
Why?
|
| Nucleosides | 1 | 1974 | 138 | 0.030 |
Why?
|
| Giant Cells | 2 | 1992 | 187 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 1997 | 1783 | 0.030 |
Why?
|
| Endometriosis | 1 | 2002 | 838 | 0.030 |
Why?
|
| Aotidae | 3 | 1998 | 59 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1998 | 573 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 708 | 0.030 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1976 | 371 | 0.030 |
Why?
|
| Neurites | 1 | 1995 | 388 | 0.030 |
Why?
|
| Phagocytes | 1 | 1995 | 296 | 0.030 |
Why?
|
| Cattle | 3 | 1993 | 3917 | 0.030 |
Why?
|
| Massachusetts | 1 | 2006 | 8660 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2016 | 1245 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 1994 | 111 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 1800 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 1996 | 927 | 0.030 |
Why?
|
| Escherichia coli | 2 | 1996 | 4216 | 0.030 |
Why?
|
| Health Personnel | 1 | 2006 | 3217 | 0.030 |
Why?
|
| Hyperplasia | 3 | 1996 | 1185 | 0.030 |
Why?
|
| Heat-Shock Proteins | 2 | 1988 | 820 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 1997 | 705 | 0.030 |
Why?
|
| Blotting, Southern | 2 | 1992 | 803 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 936 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 1994 | 323 | 0.030 |
Why?
|
| Burkitt Lymphoma | 2 | 1984 | 326 | 0.030 |
Why?
|
| Antibodies | 2 | 2008 | 2459 | 0.030 |
Why?
|
| Intestine, Small | 1 | 1998 | 1240 | 0.030 |
Why?
|
| Cell Separation | 1 | 1997 | 1750 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 1991 | 128 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1479 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1991 | 122 | 0.020 |
Why?
|
| Influenza A virus | 1 | 2015 | 457 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 1120 | 0.020 |
Why?
|
| Lymphadenitis | 2 | 1989 | 98 | 0.020 |
Why?
|
| Cross Reactions | 3 | 1998 | 841 | 0.020 |
Why?
|
| Meningoencephalitis | 2 | 1990 | 78 | 0.020 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 1991 | 99 | 0.020 |
Why?
|
| Opportunistic Infections | 2 | 1994 | 389 | 0.020 |
Why?
|
| Africa, Western | 1 | 1991 | 154 | 0.020 |
Why?
|
| TATA Box | 1 | 1990 | 128 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 427 | 0.020 |
Why?
|
| Mauritius | 1 | 2010 | 2 | 0.020 |
Why?
|
| Microscopy, Electron | 3 | 1989 | 2646 | 0.020 |
Why?
|
| Disease Reservoirs | 1 | 1991 | 131 | 0.020 |
Why?
|
| Immunoblotting | 2 | 1991 | 1683 | 0.020 |
Why?
|
| Teniposide | 1 | 1989 | 10 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 2556 | 0.020 |
Why?
|
| Ethidium | 1 | 1989 | 27 | 0.020 |
Why?
|
| Colon | 1 | 1998 | 1772 | 0.020 |
Why?
|
| Granuloma | 2 | 1989 | 319 | 0.020 |
Why?
|
| Novobiocin | 1 | 1989 | 35 | 0.020 |
Why?
|
| CD4 Immunoadhesins | 1 | 2009 | 12 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 2419 | 0.020 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 1989 | 65 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 1991 | 345 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3850 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1989 | 318 | 0.020 |
Why?
|
| Fetus | 1 | 1997 | 1880 | 0.020 |
Why?
|
| Uridine | 1 | 1989 | 146 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 1988 | 0.020 |
Why?
|
| Trachea | 1 | 1994 | 1076 | 0.020 |
Why?
|
| Splenic Diseases | 1 | 1989 | 94 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 1988 | 55 | 0.020 |
Why?
|
| Biological Evolution | 2 | 1993 | 1079 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1991 | 902 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2019 | 2720 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6539 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2016 | 1058 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1952 | 0.020 |
Why?
|
| Equine Infectious Anemia | 1 | 1987 | 1 | 0.020 |
Why?
|
| Pneumonia, Progressive Interstitial, of Sheep | 1 | 1987 | 2 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 1996 | 1171 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1998 | 2750 | 0.020 |
Why?
|
| Models, Animal | 2 | 2006 | 2172 | 0.020 |
Why?
|
| AIDS-Related Complex | 1 | 1987 | 110 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1992 | 2008 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1994 | 1320 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1991 | 2085 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 16674 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2004 | 2327 | 0.020 |
Why?
|
| Libya | 1 | 2006 | 9 | 0.020 |
Why?
|
| Goats | 1 | 1987 | 171 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 1990 | 796 | 0.020 |
Why?
|
| Spodoptera | 2 | 1998 | 153 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1993 | 711 | 0.020 |
Why?
|
| Genes | 2 | 1988 | 1893 | 0.020 |
Why?
|
| Immunohistochemistry | 4 | 1999 | 11360 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5755 | 0.020 |
Why?
|
| Lymphocryptovirus | 1 | 2006 | 14 | 0.020 |
Why?
|
| Jurisprudence | 1 | 2006 | 110 | 0.020 |
Why?
|
| Photofluorography | 1 | 1985 | 4 | 0.020 |
Why?
|
| Horses | 1 | 1987 | 304 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2006 | 168 | 0.020 |
Why?
|
| Kenya | 1 | 1989 | 685 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1987 | 916 | 0.020 |
Why?
|
| Langerhans Cells | 1 | 1987 | 173 | 0.020 |
Why?
|
| Cell Cycle | 1 | 1994 | 2963 | 0.020 |
Why?
|
| Camptothecin | 1 | 1989 | 576 | 0.020 |
Why?
|
| Defective Viruses | 1 | 1986 | 112 | 0.020 |
Why?
|
| Collagen | 1 | 1994 | 2681 | 0.020 |
Why?
|
| Acute Disease | 1 | 2016 | 7150 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 1344 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2001 | 4255 | 0.020 |
Why?
|
| Chickens | 1 | 1988 | 864 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1994 | 4183 | 0.020 |
Why?
|
| Cats | 1 | 1987 | 986 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2006 | 311 | 0.020 |
Why?
|
| Neoplasms, Experimental | 3 | 1976 | 1272 | 0.020 |
Why?
|
| Pregnancy | 2 | 2018 | 29140 | 0.020 |
Why?
|
| Cytidine | 2 | 1976 | 68 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 2 | 1986 | 524 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2002 | 1574 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1994 | 6380 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1993 | 1837 | 0.020 |
Why?
|
| Homozygote | 1 | 2010 | 1787 | 0.020 |
Why?
|
| Introns | 1 | 1988 | 991 | 0.020 |
Why?
|
| Base Pairing | 1 | 2005 | 141 | 0.020 |
Why?
|
| Africa | 1 | 1987 | 672 | 0.020 |
Why?
|
| Ki-67 Antigen | 2 | 1998 | 644 | 0.020 |
Why?
|
| Stem Cells | 1 | 1998 | 3566 | 0.020 |
Why?
|
| Reference Values | 2 | 1990 | 4974 | 0.020 |
Why?
|
| Autoradiography | 1 | 1985 | 745 | 0.020 |
Why?
|
| Tanzania | 1 | 1989 | 1346 | 0.020 |
Why?
|
| Sheep | 1 | 1987 | 1437 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 10940 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 8316 | 0.010 |
Why?
|
| Antigens, Neoplasm | 2 | 2005 | 1988 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14563 | 0.010 |
Why?
|
| Brain | 5 | 2014 | 26345 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 1991 | 768 | 0.010 |
Why?
|
| Inflammation | 2 | 2016 | 10629 | 0.010 |
Why?
|
| Immunotherapy | 2 | 2009 | 4437 | 0.010 |
Why?
|
| Chronic Disease | 2 | 2010 | 9139 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 2004 | 258 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 2004 | 254 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3639 | 0.010 |
Why?
|
| Thailand | 1 | 2004 | 299 | 0.010 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1982 | 16 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1374 | 0.010 |
Why?
|
| Administration, Rectal | 1 | 2002 | 72 | 0.010 |
Why?
|
| Sex Factors | 2 | 1994 | 10394 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2005 | 765 | 0.010 |
Why?
|
| Synteny | 1 | 2001 | 79 | 0.010 |
Why?
|
| Injections | 1 | 2005 | 839 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 253 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39001 | 0.010 |
Why?
|
| 5-Methylcytosine | 1 | 1982 | 152 | 0.010 |
Why?
|
| Virus Activation | 1 | 2003 | 319 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9440 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21824 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1981 | 111 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 1981 | 109 | 0.010 |
Why?
|
| Vaccines | 1 | 1989 | 823 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1988 | 1403 | 0.010 |
Why?
|
| Cytosine Nucleotides | 1 | 1979 | 11 | 0.010 |
Why?
|
| Consumer Product Safety | 1 | 2000 | 122 | 0.010 |
Why?
|
| Age Factors | 2 | 1994 | 18355 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15518 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 1423 | 0.010 |
Why?
|
| Poly A | 2 | 1976 | 185 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1962 | 0.010 |
Why?
|
| Drug Design | 1 | 2004 | 1075 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1998 | 263 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11478 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1999 | 462 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 1680 | 0.010 |
Why?
|
| Adult | 3 | 2017 | 213889 | 0.010 |
Why?
|
| Lung | 1 | 1996 | 9858 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 1997 | 116 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 1998 | 237 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1985 | 4737 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 561 | 0.010 |
Why?
|
| United States | 3 | 2017 | 69859 | 0.010 |
Why?
|
| Vaccines, Inactivated | 1 | 1997 | 184 | 0.010 |
Why?
|
| Liver Neoplasms | 4 | 1976 | 4251 | 0.010 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 1976 | 12 | 0.010 |
Why?
|
| Ammonium Sulfate | 1 | 1976 | 29 | 0.010 |
Why?
|
| Ribonucleotides | 1 | 1976 | 117 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4749 | 0.010 |
Why?
|
| Waxes | 1 | 1975 | 17 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1976 | 284 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1998 | 793 | 0.010 |
Why?
|
| E-Selectin | 1 | 1998 | 579 | 0.010 |
Why?
|
| Phosphothreonine | 1 | 1995 | 63 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1998 | 707 | 0.010 |
Why?
|
| Survival Rate | 1 | 1990 | 12786 | 0.010 |
Why?
|
| Genes, gag | 1 | 1994 | 61 | 0.010 |
Why?
|
| Chromatography | 1 | 1974 | 206 | 0.010 |
Why?
|
| RNA, Ribosomal | 1 | 1976 | 244 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1974 | 110 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1995 | 457 | 0.010 |
Why?
|
| Larva | 1 | 1996 | 515 | 0.010 |
Why?
|
| Guanosine | 1 | 1974 | 61 | 0.010 |
Why?
|
| Titrimetry | 1 | 1994 | 36 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1975 | 549 | 0.010 |
Why?
|
| Cellulose | 1 | 1974 | 121 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1974 | 251 | 0.010 |
Why?
|
| Child | 2 | 2006 | 77637 | 0.010 |
Why?
|
| Encephalopathy, Bovine Spongiform | 1 | 1993 | 5 | 0.010 |
Why?
|
| Skin | 2 | 1998 | 4372 | 0.010 |
Why?
|
| Integrins | 1 | 1998 | 846 | 0.010 |
Why?
|
| Manganese | 1 | 1976 | 406 | 0.010 |
Why?
|
| Magnesium | 1 | 1976 | 813 | 0.010 |
Why?
|
| Poliomyelitis | 1 | 1993 | 103 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1974 | 572 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1999 | 2692 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1976 | 1728 | 0.010 |
Why?
|
| Liver | 1 | 1986 | 7479 | 0.010 |
Why?
|
| Detergents | 1 | 1990 | 230 | 0.010 |
Why?
|
| Encephalomyelitis | 1 | 1990 | 34 | 0.010 |
Why?
|
| Membranes | 1 | 1990 | 173 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1976 | 3701 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1996 | 3585 | 0.010 |
Why?
|
| Adenosine | 1 | 1974 | 825 | 0.010 |
Why?
|
| Regeneration | 1 | 1998 | 1486 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1990 | 353 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 1679 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2004 | 3308 | 0.010 |
Why?
|
| Hybridomas | 1 | 1990 | 452 | 0.010 |
Why?
|
| Guinea-Bissau | 1 | 1988 | 5 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15067 | 0.010 |
Why?
|
| Base Composition | 1 | 1988 | 293 | 0.000 |
Why?
|
| Solubility | 1 | 1990 | 1088 | 0.000 |
Why?
|
| Neoplasms | 2 | 1994 | 21675 | 0.000 |
Why?
|
| DNA Probes | 1 | 1989 | 560 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1988 | 829 | 0.000 |
Why?
|
| Cell Count | 1 | 1991 | 1855 | 0.000 |
Why?
|
| Leukocytes | 1 | 1994 | 2044 | 0.000 |
Why?
|
| Biopsy | 1 | 1998 | 6750 | 0.000 |
Why?
|
| Survivors | 1 | 1996 | 2291 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1987 | 719 | 0.000 |
Why?
|
| Neutrophils | 1 | 1998 | 3718 | 0.000 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1984 | 31 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1997 | 4552 | 0.000 |
Why?
|
| RNA Polymerase II | 1 | 1988 | 548 | 0.000 |
Why?
|
| DNA, Circular | 1 | 1984 | 97 | 0.000 |
Why?
|
| Feedback | 1 | 1987 | 795 | 0.000 |
Why?
|
| Middle Aged | 1 | 2017 | 213241 | 0.000 |
Why?
|
| Prevalence | 1 | 1999 | 15211 | 0.000 |
Why?
|
| Apoptosis | 1 | 1998 | 9718 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1994 | 9731 | 0.000 |
Why?
|
| Pancreas | 1 | 1985 | 1686 | 0.000 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 1977 | 24 | 0.000 |
Why?
|
| S-Adenosylhomocysteine | 1 | 1977 | 41 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1999 | 40545 | 0.000 |
Why?
|
| Poly I-C | 1 | 1977 | 114 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1977 | 553 | 0.000 |
Why?
|
| Prognosis | 1 | 1997 | 29052 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1986 | 2951 | 0.000 |
Why?
|
| S-Adenosylmethionine | 1 | 1977 | 212 | 0.000 |
Why?
|
| RNA, Transfer | 1 | 1977 | 316 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1994 | 25609 | 0.000 |
Why?
|
| Endonucleases | 1 | 1977 | 380 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1977 | 2029 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1986 | 5692 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1988 | 77410 | 0.000 |
Why?
|
| Aged | 1 | 1976 | 163178 | 0.000 |
Why?
|